Adhesion barrier is
a medical implant used in patients with abdominal or pelvic laparotomy as an
alternative to the removal of postoperative adhesions between the abdominal
wall and the underlying viscera.
Market Dynamics
The adhesion
barrier market is expected to expand at a steady growth rate.
Significant factors impacting the market growth include rising surgical
procedures for small bowel obstruction, infertility and chronic pelvic pain,
and cost-effective adhesion prevention. The majority of laparoscopic procedures
contribute to adhesions. It is estimated that more than 400,000 laparotomies
are conducted annually in the United States for small bowel obstruction. In the
United States, obstetricians-gynecologists have been shown to perform two of the
most common surgical procedures, involving cesarean delivery and abdominal
hysterectomy, which is associated with the risk of developing pelvic adhesions.
The study found that adhesions occur in approximately 97% of abdominal
interventions that cause chronic pain,
infertility, and intestinal obstruction. Moreover, cost-effective prevention of
adhesions is also driving the growth of the market. For open surgery, the
adhesion barrier lowers the cost of surgery relative to no adhesion barrier,
i.e., USD 4.376 versus USD 4.482. A four-year study was conducted in the US,
and it was found that the average cost of colorectal surgery had been reduced
to USD 106, from USD 4.482 without an adhesion barrier to USD 4.376 with an
adhesion barrier.
However, the risk
of the use of the adhesion barrier in patients with a history of
hypersensitivity and the choice of adhesion barriers among surgeons may hinder
the growth of the market.
Segmentation
The global market
for adhesion barrier has been segmented into product, formulation, severity,
and application.
Side-effect, the
worldwide market for bond hindrance has been portioned into manufactured grip
boundaries and normal attachment obstructions. The manufactured attachment
obstructions are additionally isolated into hyaluronic corrosive, recovered
cellulose, and polyethylene glycol. Manufactured attachment obstructions
represented the biggest piece of the pie because of a few benefits over regular
bond boundaries, including high biocompatibility, bioresorbable property, and
cost-viability of these items. The regular grip obstructions are additionally
sectioned into collagen and protein, fibrin.
By detailing, the
worldwide bond hindrance has been portioned into film, gel, and fluid. Film
based attachment obstructions are projected to hold the biggest portion of the
overall industry because of better taking care of qualities and demonstrated
positive outcomes. Driving makers for these items are J&J, Sanofi, and
others. Gel-based grip obstructions are made out of polyethylene oxide and
sodium carboxymethylcellulose, with defensive action. Fluid based grip
hindrances are meant to make a site-explicit obstruction on an objective
By severity, the
global market for adhesion barrier has been segmented into mild adhesion and
severe adhesion. Mild adhesion was the largest market share. According to a
study of 122 patients, only three patients were found to have switched from
mild to severe adhesion. Example of mild adhesion includes filmy and avascular.
Severe adhesion is expected to hold the least market share. Example of severe
adhesion includes organized, cohesive, vascular, and dense
By application, the
global market for adhesion barrier has been described by gynecological
surgeries. Gynecological surgeries are projected to have the largest market
share due to a large number of gynecological procedures, and many women are
likely to experience post-surgical adhesions. It is estimated that 90 % of
patients undergo main abdominal surgery and that between 55% and 100% of
females undergo pelvic surgery develop adhesions.
Regional Analysis
Regionally, the
global adhesion barrier market has been segmented into the Americas, Europe,
the and Asia Pacific.
The Americas drove
the grip obstruction market in 2019 and is supposed to keep on ruling the
market all through the gauge period. This is because of the presence of an
enormous number of clinical gadget firms, an ascent in innovative work, an expansion
in laparoscopy methodology, and countless patients. In excess of 400,000
laparotomies are directed every year in the United States alone for little
inside obstacle.
Europe is projected
to hold the second-biggest offer because of expanded utilization of cutting-edge
innovations and expanded item advancement by existing makers.
The Asia Pacific is
projected to rise at the highest rate of growth during the study period. This
is due to widely populated countries such as China, India, Indonesia, Pakistan,
and Bangladesh, growing gynecological procedures, and increasing government initiatives
to raise awareness of women's related diseases.
Key Players
The global adhesion
barrier market players are Johnson & Johnson, Atrium Medical Corporation
(A Part of Getinge Group), Betatech Medical, R. Bard, FzioMed, Innocoll
Holdings, Anika Therapeutics, Integra LifeSciences Holdings Corporation, Baxter
International, MAST Biosurgery, Normedi Nordic., Sanofi.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th
Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments